The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Mechanisms of hepatocellular carcinoma progression
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. It is the second leading cause of cancer-related deaths worldwide, with a very poor prognosis. In the United States, there has been only minimal improvement in the prognosis for HCC patients over the past 15 years. Details of the molecular mechanisms and other mechanisms of HCC progression remain unclear. Consequently, there is an urgent need for better understanding of these mechanisms. HCC is often diagnosed at advanced stages, and most patients will therefore need systemic therapy, with sorafenib being the most common at the present time. However, sorafenib therapy only minimally enhances patient survival. This review provides a summary of some of the known mechanisms that either cause HCC or contribute to its progression. Included in this review are the roles of viral hepatitis, non-viral hepatitis, chronic alcohol intake, genetic predisposition and congenital abnormalities, toxic exposures, and autoimmune diseases of the liver. Well-established molecular mechanisms of HCC progression such as epithelial-mesenchymal transition, tumor-stromal interactions and the tumor microenvironment, cancer stem cells, and senescence bypass are also discussed. Additionally, we discuss the roles of circulating tumor cells, immunomodulation, and neural regulation as potential new mechanisms of HCC progression. A better understanding of these mechanisms could have implications for the development of novel and more effective therapeutic and prognostic strategies, which are critically needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Brabletz, T., Kalluri, R., Nieto, M. A., & Weinberg, R. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.118 · Cited by 1,961
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, J. M., Montal, R., Sia, D., & Finn, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0073-4 · Cited by 1,938
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Jordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, D., Villanueva, A., Friedman, S. L., & Llovet, J. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,153
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2375 · Cited by 1,118
Oncogenic roles of EMT-inducing transcription factors
Puisieux, A., Brabletz, T., & Caramel, J. (2014) · Nature Cell Biology · doi:10.1038/ncb2976 · Cited by 1,040
Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Ye, X., & Weinberg, R. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.07.012 · Cited by 1,013
Tackling the cancer stem cells — what challenges do they pose?
Pattabiraman, D. R., & Weinberg, R. A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4253 · Cited by 990
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Hernandez–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.002 · Cited by 722
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Rowe, J., Ghouri, Y., & Mian, I. (2017) · Journal of Carcinogenesis · doi:10.4103/jcar.jcar_9_16 · Cited by 719
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Substantial contribution of extrinsic risk factors to cancer development
Wu, S., Powers, S., Zhu, W., & Hannun, Y. A. (2016) · Nature · doi:10.1038/nature16166 · Cited by 666
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636
CD13 is a therapeutic target in human liver cancer stem cells
Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H. M., Akita, H., Takiuchi, D., Hatano, H., Nagano, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42550 · Cited by 605
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Wellenstein, M. D., & de Visser, K. E. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.004 · Cited by 589
EMT as the ultimate survival mechanism of cancer cells
Tiwari, N., Gheldof, A., Tatari, M., & Christofori, G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.013 · Cited by 512
Impact of Stress on Cancer Metastasis
Moreno-Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 510
A conduit to metastasis: circulating tumor cell biology
Micalizzi, D. S., Maheswaran, S., & Haber, D. A. (2017) · Genes & Development · doi:10.1101/gad.305805.117 · Cited by 446
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Luo, J.-L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., & Karin, M. (2007) · Nature · doi:10.1038/nature05656 · Cited by 436
Zhu, Z., Hao, X., Yan, M., Yao, M., Ge, C., Gu, J., & Li, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.24868 · Cited by 434
The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
Yang, J. D., Nakamura, I., & Roberts, L. R. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.007 · Cited by 390
Dimitroulis, D., Damaskos, C., Valsami, S., Davakis, S., Garmpis, N., Spartalis, E., Athanasiou, A., Moris, D., Sakellariou, S., Kykalos, S., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5282 · Cited by 330
Hagel, M., Miduturu, C., Sheets, M., Rubin, N., Weng, W., Stransky, N., Bifulco, N., Kim, J. L., Hodous, B., Brooijmans, N., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1029 · Cited by 313
Diurnal cortisol rhythm as a predictor of lung cancer survival
Sephton, S. E., Lush, E., Dedert, E. A., Floyd, A. R., Rebholz, W. N., Dhabhar, F. S., Spiegel, D., & Salmon, P. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.019 · Cited by 309
Sorafenib: A Review in Hepatocellular Carcinoma
Keating, G. M. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0484-7 · Cited by 308
Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
Daher, S., Massarwa, M., Benson, A. A., & Khoury, T. (2018) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00031 · Cited by 304
Qi, L.-N., Xiang, B.-D., Wu, F.-X., Ye, J.-Z., Zhong, J.-H., Wang, Y.-Y., Chen, Y.-Y., Chen, Z.-S., Ma, L., Chen, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2459 · Cited by 301
Letouzé, E., Shinde, J., Renault, V., Couchy, G., Blanc, J.-F., Tubacher, E., Bayard, Q., Bacq, D., Meyer, V., Semhoun, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01358-x · Cited by 294
The yin and yang of evasion and immune activation in HCC
Makarova-Rusher, O. V., Medina-Echeverz, J., Duffy, A. G., & Greten, T. F. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.038 · Cited by 293
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
Amann, T., Bataille, F., Spruss, T., Mühlbauer, M., Gäbele, E., Schölmerich, J., Kiefer, P., Bosserhoff, A., & Hellerbrand, C. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01087.x · Cited by 277
The evolving concept of liver cancer stem cells
Nio, K., Yamashita, T., & Kaneko, S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0572-9 · Cited by 274
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
Ikeda, M., Morizane, C., Ueno, M., Okusaka, T., Ishii, H., & Furuse, J. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyx180 · Cited by 272
Aflatoxins as a cause of hepatocellular carcinoma.
Kew, M. C. (2013) · PubMed · Cited by 263
Golabi, P., Fazel, S., Otgonsuren, M., Sayiner, M., Locklear, C. T., & Younossi, Z. M. (2017) · Medicine · doi:10.1097/md.0000000000005904 · Cited by 257
Chen, L., Guo, P., He, Y., Chen, Z., Chen, L., Luo, Y., Qi, L., Liu, Y., Wu, Q., Cui, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0534-9 · Cited by 253
Cancer stem cell plasticity and tumor hierarchy
Cabrera, M. C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.27 · Cited by 252
Schulze, K., Gasch, C., Staufer, K., Nashan, B., Lohse, A. W., Pantel, K., Riethdorf, S., & Wege, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28230 · Cited by 244
Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R., & Sarin, S. K. (2013) · Liver Cancer · doi:10.1159/000343852 · Cited by 238
Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
van de Stolpe, A., Pantel, K., Sleijfer, S., Terstappen, L. W., & den Toonder, J. M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1254 · Cited by 218
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer
Vona, G., Estepa, L., Béroud, C., Damotte, D., Capron, F., Nalpas, B., Mineur, A., Franco, D., Lacour, B., Pol, S., et al. (2004) · Hepatology · doi:10.1002/hep.20091 · Cited by 215
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
Dhanasekaran, R., Bandoh, S., & Roberts, L. R. (2016) · F1000Research · doi:10.12688/f1000research.6946.1 · Cited by 212
Jayachandran, A., Dhungel, B., & Steel, J. C. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0307-9 · Cited by 208
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
Tarocchi, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11630 · Cited by 186
Sorrentino, P., D’Angelo, S., Ferbo, U., Micheli, P., Bracigliano, A., & Vecchione, R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.011 · Cited by 183
Hepatitis C virus-induced hepatocarcinogenesis
Bartosch, B., Thimme, R., Blum, H. E., & Zoulim, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.008 · Cited by 178
Epigenetics in liver disease: from biology to therapeutics
Hardy, T., & Mann, D. A. (2016) · Gut · doi:10.1136/gutjnl-2015-311292 · Cited by 176
Targets for immunotherapy of liver cancer
Greten, T. F., & Sangro, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.007 · Cited by 168
Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults
Campbell, P. T., Newton, C. C., Freedman, N. D., Koshiol, J. E., Alavanja, M. C. R., Freeman, L. E. B., Buring, J. E., Chan, A. T., Chong, D. Q., Datta, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0787 · Cited by 165
Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers
Singh, A. K., Kumar, R., & Pandey, A. K. (2018) · Current Chemical Genomics and Translational Medicine · doi:10.2174/2213988501812010009 · Cited by 165
Cancer stem cell targeted therapy: progress amid controversies
Wang, T., Shigdar, S. L., Gantier, M. P., Hou, Y., Wang, L., Li, Y., Shamaileh, H. A., Yin, W., Zhou, S., Zhao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6176 · Cited by 161
Li, Y., Xu, S.-C., Li, J., Han, K.-Q., Pi, H.-F., Zheng, L., Zuo, G.-H., Huang, X.-B., Li, H.-Y., Zhao, H.-Z., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.347 · Cited by 159
Guo, W., Sun, Y., Shen, M., Ma, X.-L., Wu, J., Zhang, C.-Y., Zhou, Y., Xu, Y., Hu, B., Zhang, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1753 · Cited by 153
Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
Nishida, N., & Kudo, M. (2016) · Oncology · doi:10.1159/000451015 · Cited by 142
The Role of Aflatoxins in Hepatocellular Carcinoma
Wu, H.-C., & Santella, R. M. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.7238 · Cited by 135
Immunology of hepatocellular carcinoma
Sachdeva, M., Chawla, Y. K., & Arora, S. K. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2080 · Cited by 134
Emerging therapies in advanced hepatocellular carcinoma
Medavaram, S., & Zhang, Y. (2018) · Experimental Hematology and Oncology · doi:10.1186/s40164-018-0109-6 · Cited by 127
Li, J., Han, X., Yu, X., Xu, Z., Yang, G., Liu, B., & Xiu, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0893-1 · Cited by 125
Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
Wang, N., Wang, S., Li, M., Hu, B., Liu, L., Yang, S., Yang, S., Gong, Z., Lai, P. B. S., & Chen, G. G. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918816287 · Cited by 121
Diurnal cortisol and survival in epithelial ovarian cancer
Schrepf, A., Thaker, P. H., Goodheart, M. J., Bender, D., Slavich, G. M., Dahmoush, L., Penedo, F. J., DeGeest, K., Méndez, L., Lubaroff, D. M., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.010 · Cited by 115
Lang, M., David, V., & Giese‐Davis, J. (2015) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2015.0005 · Cited by 109
Tansel, A., Katz, L. H., El‐Serag, H. B., Thrift, A. P., Parepally, M., Shakhatreh, M. H., & Kanwal, F. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.006 · Cited by 109
Epigenetic Upregulation of HGF and c-Met Drives Metastasis in Hepatocellular Carcinoma
Ogunwobi, O. O., Puszyk, W. M., Dong, H., & Liu, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063765 · Cited by 102
Self-citationOkajima, W., Komatsu, S., Ichikawa, D., Miyamae, M., Ohashi, T., Imamura, T., Kiuchi, J., Nishibeppu, K., Arita, T., Konishi, H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i31.5650 · Cited by 101
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
Lindblad, M., Rodríguez, L. A. G., Chandanos, E., & Lagergren, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602906 · Cited by 97
D’Avola, D., Villacorta-Martín, C., Martins-Filho, S. N., Craig, A. J., Labgaa, I., von Felden, J., Allette, K., Bonaccorso, A., Tabrizian, P., Hartmann, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30047-y · Cited by 90
von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S., & Wege, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21208 · Cited by 89
Parity, reproductive factors, and the risk of pancreatic cancer in women.
Skinner, H. G., Michaud, D. S., Colditz, G. A., Giovannucci, E. L., Stampfer, M. J., Willett, W. C., & Fuchs, C. S. (2003) · PubMed · Cited by 86
Cassoni, P., Sapino, A., Fortunati, N., Munaron, L., Chini, B., & Bussolati, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970717)72:2<340::aid-ijc23>3.0.co;2-i · Cited by 85
Lin, Y., Tan, C., Chen, C.-W., Ou, D., Cheng, A., & Hsu, C. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1673621 · Cited by 84
Yavorkovsky, L. L., Lai, E., Ilic, Z., & Sell, S. (1995) · Hepatology · doi:10.1002/hep.1840210632 · Cited by 79
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Ramadori, P., Cubero, F. J., Liedtke, C., Trautwein, C., & Nevzorova, Y. A. (2017) · Cancers · doi:10.3390/cancers9100130 · Cited by 79
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
Ortega‐Prieto, A. M., & Dorner, M. (2017) · Vaccines · doi:10.3390/vaccines5030024 · Cited by 78
Hepatic stem cells: existence and origin
Zhang, Y., Bai, X.-F., & Huang, C.-X. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i2.201 · Cited by 76
Bralet, M., Pichard, V., & Ferry, N. (2002) · Hepatology · doi:10.1053/jhep.2002.35540 · Cited by 74
Activation of cultured rat hepatic stellate cells by tumoral hepatocytes.
Faouzi, S., Lepreux, S., Bedin, C., Dubuisson, L., Balabaud, C., Bioulac‐Sage, P., Desmoulière, A., & Rosenbaum, J. (1999) · PubMed · Cited by 72
Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury
Dong, T., Liang, Z., Bhayana, B., & Wu, M. X. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0663-y · Cited by 71
HANN, H.-W. L., Kim, C. Y., London, W. T., & Blumberg, B. S. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430304 · Cited by 69
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
Yin, C., Yuan, C., Qu, Z., Guan, Q., Chen, H., & Wang, F. (2016) · Disease Markers · doi:10.1155/2016/1427849 · Cited by 69
Steatosis and NASH in type 2 diabetes
Hu, M., Phan, F., Bourron, O., Ferré, P., & Foufelle, F. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.019 · Cited by 68
Chen, J., Cao, S., Cai, Z., Zheng, L., & Wang, Q. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170315 · Cited by 67
Non-viral causes of liver cancer: Does obesity led inflammation play a role?
Alzahrani, B., Iseli, T. J., & Hebbard, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.036 · Cited by 66
Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
Sanz-Cameno, P., Trapero-Marugán, M., Chaparro, M., Jones, E. A., & Moreno‐Otero, R. (2010) · Journal of Oncology · doi:10.1155/2010/272170 · Cited by 64
Yan, G., Wang, X., Sun, C., Zheng, X., Wei, H., Tian, Z., & Sun, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-02887-7 · Cited by 63
Fan, J., Yang, Y. K., Yuan, C., Chen, H., & Wang, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430382 · Cited by 61
Antiangiogenic Therapies for Advanced Hepatocellular Carcinoma
Sampat, K., & O’Neil, B. H. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0388 · Cited by 60
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells
Galiè, M., Sorrentino, C., Montani, M., Micossi, L. G., Carlo, E. D., D’Antuono, T., Calderan, L., Marzola, P., Benati, D., Merigo, F., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi158 · Cited by 57
Shi, C., Chen, Y., Chen, Y., Yang, Y., Wang, B., & Qi, J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s172417 · Cited by 56
Oxytocin and cancer: An emerging link
Lerman, B., Harricharran, T., & Ogunwobi, O. O. (2018) · World Journal of Clinical Oncology · doi:10.5306/wjco.v9.i5.74 · Cited by 54
Self-citationThe Biology of Cancer Stem Cells and Its Clinical Implication in Hepatocellular Carcinoma
Yoon, S. K. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.1.29 · Cited by 53
Molecular Mechanisms Underlying Hepatocellular Carcinoma
Merle, P., & TREPO, C. G. (2009) · Viruses · doi:10.3390/v1030852 · Cited by 53
HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
Fransvea, E., Paradiso, A., Antonaci, S., & Giannelli, G. (2009) · Analytical Cellular Pathology · doi:10.1155/2009/134921 · Cited by 53
Lü, Y., Lin, N., Chen, Z., & Xu, R. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2689 · Cited by 52
Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection
Álvarez-Cubero, M. J., Lorente, J. A., Robles‐Fernandez, I., Martínez, A. R., Puche, J. L. G., & Serrano, M. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7144-2_24 · Cited by 50
Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
Personeni, N., Pressiani, T., Santoro, A., & Rimassa, L. (2018) · Drugs in Context · doi:10.7573/dic.212533 · Cited by 50
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma
Sun, C., Liao, W., Deng, Z., Li, E., Feng, Q., Lei, J., Yuan, R., Zou, S., Mao, Y., Shao, J., et al. (2017) · Medicine · doi:10.1097/md.0000000000007513 · Cited by 49
Transforming growth factor‐β in liver cancer stem cells and regeneration
Rao, S., Zaidi, S., Banerjee, J., Jogunoori, W. S., Sebastian, R., Mishra, B., Nguyen, B.-N. H., Wu, R., White, J. C., Deng, C., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1062 · Cited by 46
Increased regulatory T cells in acute lymphoblastic leukemia patients
Idris, S.-Z., Hassan, N., Lee, L.-J., Noor, S. M., Osman, R., Abdul-Jalil, M., Nordin, A.-J., & Abdullah, M. (2015) · Hematology · doi:10.1179/1607845415y.0000000025 · Cited by 44
Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
Vu, N. B., Nguyen, T. T., Tran, L. C.-D., Do, C. D., Bắc, N. H., Phan, N. K., & Pham, P. V. (2012) · Cytotechnology · doi:10.1007/s10616-012-9511-9 · Cited by 42
Lenvatinib as a therapy for unresectable hepatocellular carcinoma
Spallanzani, A., Orsi, G., Andrikou, K., Gelsomino, F., Rimini, M., Riggi, L., & Cascinu, S. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1524297 · Cited by 41
Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
Mukaida, N., & Nakamoto, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i17.1839 · Cited by 39
ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells
Lin, L., Xiang, H., Liu, J., Zhang, Z., & Sun, L. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.01.001 · Cited by 39
Mikhail, S., & He, A. R. (2011) · International Journal of Hepatology · doi:10.4061/2011/486954 · Cited by 38
Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma
Zhao, F., Korangy, F., & Greten, T. F. (2012) · Digestive Diseases · doi:10.1159/000341695 · Cited by 37
Xu, H., Fu, S., Chen, Q., Gu, M., Zhou, J., Liu, C., Chen, Y., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16107 · Cited by 36
Xiao, Z., Shen, J., Zhang, L., Li, M., Hu, W., & Cho, C. H. (2018) · Oncology Letters · doi:10.3892/ol.2018.7758 · Cited by 36
Delire, B., Henriet, P., Lemoine, P., Leclercq, I. A., & Stärkel, P. (2018) · Cancer Science · doi:10.1111/cas.13628 · Cited by 35
Immunomodulation in hepatocellular cancer
Lee, S., Loecher, M., & Iyer, R. V. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.06.08 · Cited by 32
The emergence of long non-coding RNAs in hepatocellular carcinoma: an update
Peng, L., Yuan, X., Zhang, C., Peng, J., Zhang, Y., Pan, X., & Li, G. (2018) · Journal of Cancer · doi:10.7150/jca.24560 · Cited by 32
Synergistic interaction between excess hepatic iron and alcohol ingestion in hepatic mutagenesis
Asare, G. A., Bronz, M., Naidoo, V., & Kew, M. C. (2008) · Toxicology · doi:10.1016/j.tox.2008.08.024 · Cited by 29
Wu, W., Liu, S., Liang, Y., Zhou, Z., Bian, W., & Liu, X. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4798-1 · Cited by 24
Amanda, M., Dave, F., Pados, G., Tsolakidis, D., Gidron, Y., Pang, Y., Thomas, P., Hall, M., & Karteris, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3410 · Cited by 23
FK866 inhibits the epithelial‑mesenchymal transition of hepatocarcinoma MHCC97‑H cells
Zhang, B., Shi, D., Zhang, X., Liang, G., Liu, W., & Qiao, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9541 · Cited by 23
Waist Circumference Might Be a Predictor of Primary Liver Cancer: A Population-Based Cohort Study
Wei, L., Li, N., Wang, G., Feng, X., Lyu, Z., Li, X., Wen, Y., Chen, Y., Chen, H., Chen, S., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00607 · Cited by 22
Lugade, A. A., Kalathil, S. G., Miller, A., Iyer, R. V., & Thanavala, Y. M. (2013) · OncoImmunology · doi:10.4161/onci.24679 · Cited by 17
Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
Machida, K. (2016) · Hepatology International · doi:10.1007/s12072-016-9777-7 · Cited by 17
New challenges in psycho‐oncology: Neural regulation of the cancer genome
Cole, S. W. (2018) · Psycho-Oncology · doi:10.1002/pon.4838 · Cited by 15
Impact of emotional support on serum cortisol in breast cancer patients
Webster, S., Chandrasekaran, S., Vijayaragavan, R., & Sethu, G. (2016) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.179607 · Cited by 11
Siriwardana, R. C., Niriella, M. A., Dassanayake, A. S., Ediriweera, D. S., Gunetilleke, B., Sivasundaram, T., & de Silva, J. (2017) · Liver Cancer · doi:10.1159/000477266 · Cited by 11
Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Huaman, J., Bach, C., Ilboudo, A., & Ogunwobi, O. O. (2017) · Molecular pathology library · doi:10.1007/978-3-319-68082-8_8 · Cited by 10
Self-citationBonding With β-Cells—A Role for Oxytocin in Glucose Handling
Scerbo, M., & Gerdes, J. (2017) · Diabetes · doi:10.2337/dbi16-0053 · Cited by 9
Cited by
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Zeng, C., Huang, W., Li, Y., & Weng, H. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00951-w · Cited by 634
Wu, T., Liao, L., Wu, T., Chen, S., Yi, Q., & Xu, M. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2283328 · Cited by 20
Metadata
- Authors
- Ogunwobi, O. O., Harricharran, T., Huaman, J., Galuza, A., Odumuwagun, O., Tan, Y., Ma, G. X., & Nguyen, M. T.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2019-05-21
- Volume
- 25
- Issue
- 19
- Pages
- 2279-2293
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2945856748
- Cited by
- 291
- References
- 136
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.